Treatment of American cutaneous leishmaniasis: A comparison between low dosage (5 mg/kg/day) and high dosage (20 mg/kg/day) antimony regimens;Traitement de la leishmanoise cutanee Americaine: Une comparison entre faible dose (5mg/kg/jour) et haute dose (20mg/kg/jour) d'antimoine

Pathologie Biologie

Volumn 45, Issue 6, 1997, Pages 496-499

  Oliveira Neto, M P ^a   Schubach, A ^a   Mattos, M ^a   Goncalves Costa, S C ^a   Pirmez, C ^a  

^a Funda??o Oswaldo Cruz   (Brazil)

Author keywords

American cutaneous leishmaniasis (ACL); Antimony; Therapy

Indexed keywords

ANTIMONY; GLUCANTHIME; MEGLUMINE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTHRALGIA; ARTICLE; ASTHENIA; BRAZIL; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EPITHELIZATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEISHMANIA BRAZILIENSIS; MALAISE; MALE; MYALGIA; PARASITE CULTIVATION; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SKIN LEISHMANIASIS;

ADULT; ANTIMONY; ANTIPROTOZOAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; LEISHMANIASIS, CUTANEOUS; MEGLUMINE; ORGANOMETALLIC COMPOUNDS;

EID: 0030849038     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)